Skip to main content

Table 3 The laboratory findings of 7 patients with COVID-19 (Admission)

From: Clinical features and outcomes of seven patients with COVID-19 in a family cluster

Variable case1 case2 case3 case4 case5 case6 case7
PH (7.35–7.45) 7.32 7.4 7.375 7.386 7.352 7.369 7.333
PO2 (80-100 mmHg) 90.1 108 77.3 63.2 73.5 87.3 92.6
PCO2 (35-45 mmHg) 40.4 41 41.4 34.9 44.4 43.8 97.2
OI (400-500 mmHg) 310 372 368 253 350 415 440
White blood cell count (4–10 × 109/L) 5.93 9.12 6.13 9.11 7.74 5.98 5.11
Neutrophil percentage (45–77%) 52.6 81.3 60.4 84.6 47.4 52.9 54.7
Lymphocyte count (0.8–4× 109/L) 2.34 1.23 1.91 0.29 3.35 2.25 1.73
Haemoglobin (131-172 g/L) 163 132 129 85 164 150 172
Eosinophil percentage (0.5–5%) 1.6 0.3 0.8 0.6 1.5 4 2.4
Platelet count (100–300× 109/ L) 318 159 204 211 283 323 265
ERS (0-20 mm /h) 46 29 6 89 41 64 28
CRP (0-8 mg/L) 2.84 2.24 4 12.31 16 15 22
Procalcitonin (≤0.5(ng/ml) 0.01 0.032 0.041 1.34 0.022 < 0.02 0.041
GLU (3.9–6.1 mmol/L) 5.1 7.2 4.7 6.8 4.4 5.3 4.2
Alanine aminotransferase (8- 40 U/L) 27 18 6 17 9 20 7
Aspartate aminotransferase (5 -40 U/L) 22 32 17 18 23 18 19
Urea nitrogen (2.9–8.2 mmol /L) 4.7 3.5 3.7 5.6 6.2 3.1 2.9
Creatinine (40-106umol/L) 75.2 52.5 42.5 65 85.7 50.8 57.6
Glutamyl transpeptidase (8- 58 U/L) 41 19 12 18 22 18 14
Lactate dehydrogenase (115 -220 U/L) 192 94 203 184 226 170 181
Total bilirubin (5.1–20 umol /L) 6.6 6.4 5.7 5.4 5.7 5.8 21.5
Direct bilirubin (0–6.8umol/ L) 0.2 5 1 0.6 2.4 2 7.3
Indirect bilirubin (2-17umol/ L) 6.4 1.4 4.7 4.8 3.3 3.8 14.2
Myoglobin (<21 ng/ml) 12 18 <21 20 <21 <21 <21
Creatine kinase (25-196 U/ L) 76 10 81 28 87 44 37
Creatinase isoenzyme (0–26 U/L) 7 21 6 22 16 15 7
Troponin (0–0.1 ng/ml) 0.01 0.001 <0.003 0.012 0.005 <0.003 0.003
APTT (26-44 s) 37.3 32.8 32.4 34.9 35.5 35.1 35.2
D-dimer (0-1 mg/ml) 0.4 0.47 0.43 0.52 0.43 0.44 0.45
BNP (<300 pg/ml) 3143